Professional Documents
Culture Documents
Cipla
Cipla
Cipla
Today, we are one of the worlds largest generic pharmaceutical companies with a presence in over 170 countries. We are renowned for making affordable, world-class medicines that meet the needs of patients across therapies. We also offer services like consulting, commissioning, plant engineering, technical know-how transfer and support. Incorporated Corporate Office Chairman Executive ViceChairman Listing 1935 Cipla Ltd., Mumbai Central, Mumbai 400 008, India Dr. Yusuf K. Hamied Mr. M.K. Hamied
Equity Shares: BSE Limited and National Stock Exchange of India Limited Global Depository Receipts: Luxembourg Stock Exchange USD 1.5 billion 20,000 US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among others
Highlights
One of the worlds largest generic companies. Over 2,000 products, 65 therapeutic categories, over 40 dosage forms.34 state-of-the-art manufacturing facilities approved by major international regulatory agencies Continuous innovation in R&D; over 20 world firsts. contactus@cipla.com +91 22 23082891, +91 22 23095521
Contact